Maraki Sofia, Vardakas Konstantinos Z, Samonis George, Perdikis Dimitrios, Mavromanolaki Viktoria Eirini, Kofteridis Diamantis P, Falagas Matthew E
Department of Clinical Microbiology, University Hospital of Heraklion, Heraklion, Greece.
Alfa Institute of Biomedical Sciences (AIBS), Athens, Greece.
Future Microbiol. 2017 Jun;12:683-693. doi: 10.2217/fmb-2016-0216. Epub 2017 May 25.
To study the evolution in the susceptibility of Enterobacter spp. in Crete, Greece from 2010 to 2015.
Non-duplicate isolates were studied using automated systems. Phenotypic confirmatory tests were applied.
A total of 939 Enterobacter isolates were included. Colistin was the most active antibiotic (97.9%) followed by imipenem (96.1%), gentamicin (95.7%), tigecycline (91.8%), cefepime (89.4%), chloramphenicol (85.8%), fosfomycin (85.5%), trimethoprim/sulfamethoxazole (83.3%) and piperacillin/tazobactam (73.3%). Antibiotic resistance did not increase during the study period for most antibiotics. Lower susceptibility was observed among multidrug-resistant strains and carbapenem-nonsusceptible isolates. AmpC was the most common resistant mechanism (21%); carbapenemases (3.7%) and aminoglycoside-modifying enzymes (6.5%) were also detected.
A significant proportion of Enterobacter spp. was resistant to several antibiotics, most notably β-lactams.
研究2010年至2015年希腊克里特岛肠杆菌属细菌的药敏变化情况。
使用自动化系统对非重复分离株进行研究,并应用表型确证试验。
共纳入939株肠杆菌分离株。黏菌素是最有效的抗生素(97.9%),其次是亚胺培南(96.1%)、庆大霉素(95.7%)、替加环素(91.8%)、头孢吡肟(89.4%)、氯霉素(85.8%)、磷霉素(85.5%)、甲氧苄啶/磺胺甲恶唑(83.3%)和哌拉西林/他唑巴坦(73.3%)。在研究期间,大多数抗生素的耐药性并未增加。多重耐药菌株和碳青霉烯不敏感分离株的药敏性较低。AmpC是最常见的耐药机制(21%);还检测到碳青霉烯酶(3.7%)和氨基糖苷类修饰酶(6.5%)。
相当一部分肠杆菌属细菌对多种抗生素耐药,尤其是β-内酰胺类抗生素。